Junchen Hou

1.8k total citations · 1 hit paper
21 papers, 1.3k citations indexed

About

Junchen Hou is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Junchen Hou has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Junchen Hou's work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (10 papers) and Cancer-related molecular mechanisms research (10 papers). Junchen Hou is often cited by papers focused on MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (10 papers) and Cancer-related molecular mechanisms research (10 papers). Junchen Hou collaborates with scholars based in China, Australia and Bangladesh. Junchen Hou's co-authors include Heda Zhang, Linhong Jiang, Zhenling Ji, Dawei Sun, Jinhai Tang, Shanliang Zhong, Jianhua Zhao, Su‐Jin Yang, Dandan Wang and Siying Zhou and has published in prestigious journals such as Nature Communications, Medicine and Cell Death and Disease.

In The Last Decade

Junchen Hou

21 papers receiving 1.3k citations

Hit Papers

CircRNA: a novel type of biomarker for cancer 2017 2026 2020 2023 2017 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CircRNA: a novel type of biomarker for cancer
    2017 622 citations Heda Zhang, Linhong Jiang et al. Breast Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junchen Hou China 14 1.2k 1.1k 83 54 46 21 1.3k
Gehao Liang China 15 894 0.8× 843 0.8× 132 1.6× 127 2.4× 34 0.7× 29 1.1k
Zhenyu Zhong China 8 1.1k 1.0× 1.1k 1.0× 40 0.5× 40 0.7× 29 0.6× 11 1.2k
Erhu Fang China 16 926 0.8× 664 0.6× 107 1.3× 77 1.4× 43 0.9× 29 1.1k
Qiaozhu Zuo China 10 989 0.9× 816 0.8× 74 0.9× 88 1.6× 42 0.9× 12 1.1k
Kefeng Wang China 20 1.0k 0.9× 909 0.8× 83 1.0× 110 2.0× 39 0.8× 43 1.2k
Botai Li China 7 968 0.8× 799 0.7× 49 0.6× 79 1.5× 38 0.8× 10 1.1k
Zhuojun Zheng China 13 593 0.5× 440 0.4× 156 1.9× 66 1.2× 56 1.2× 29 827
Tingting Shao China 17 865 0.7× 754 0.7× 56 0.7× 46 0.9× 28 0.6× 39 1.0k

Countries citing papers authored by Junchen Hou

Since Specialization
Citations

This map shows the geographic impact of Junchen Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junchen Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junchen Hou more than expected).

Fields of papers citing papers by Junchen Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junchen Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junchen Hou. The network helps show where Junchen Hou may publish in the future.

Co-authorship network of co-authors of Junchen Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Junchen Hou. A scholar is included among the top collaborators of Junchen Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junchen Hou. Junchen Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Junchen, Zhixian Yao, Lei Dong, et al.. (2024). Domain generalization enables general cancer cell annotation in single-cell and spatial transcriptomics. Nature Communications. 15(1). 1929–1929. 20 indexed citations
2.
Hou, Junchen, et al.. (2024). MCC950 attenuates plasma cell mastitis in an MDSC-dependent manner. International Immunopharmacology. 131. 111803–111803. 4 indexed citations
3.
Chen, Xiu, Heda Zhang, Fang Zheng, et al.. (2024). Adipocytes promote metastasis of breast cancer by attenuating the FOXO1 effects and regulating copper homeostasis. Cancer Cell International. 24(1). 284–284. 3 indexed citations
4.
Wei, Yan, Dandan Wang, He-Da Zhang, et al.. (2022). Expression profile and prognostic values of SMC family members in HCC. Medicine. 101(42). e31336–e31336. 7 indexed citations
5.
Wang, Dandan, Jian Zhang, Linhong Jiang, et al.. (2022). Malignant adenomyoepithelioma of the breast: cases report and literature review.. PubMed. 14(12). 8788–8792. 2 indexed citations
6.
7.
Xu, Wen‐Xiu, et al.. (2021). The Emerging Role of the Interactions between Circular RNAs and RNA-binding Proteins in Common Human Cancers. Journal of Cancer. 12(17). 5206–5219. 25 indexed citations
8.
Yang, Su‐Jin, Dandan Wang, Shanliang Zhong, et al.. (2021). Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis. Cell Death and Disease. 12(5). 420–420. 99 indexed citations
9.
Zhao, Zhiqiang, Song Wei, Jinhai Tang, et al.. (2021). Autophagy Modulation and Synergistic Therapy to Combat Multidrug Resistance Breast Cancer Using Hybrid Cell Membrane Nanoparticles. Journal of Biomedical Nanotechnology. 17(7). 1404–1416. 6 indexed citations
10.
Zhang, Heda, Linhong Jiang, Shanliang Zhong, et al.. (2020). The role of long non‐coding RNAs in drug resistance of cancer. Clinical Genetics. 99(1). 84–92. 13 indexed citations
11.
He, Yunjie, Fei Deng, Shujie Zhao, et al.. (2019). Analysis of miRNA–mRNA Network Reveals miR-140-5p as a Suppressor of Breast Cancer Glycolysis Via Targeting GLUT1. Epigenomics. 11(9). 1021–1036. 52 indexed citations
12.
Chen, Xiu, Di Xu, Xingjiang Li, et al.. (2019). Latest Overview of the Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: The Past, the Present and the Future. Journal of Cancer. 10(26). 6608–6617. 38 indexed citations
13.
Zhang, Heda, Linhong Jiang, Junchen Hou, et al.. (2018). Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer. Biomedicine & Pharmacotherapy. 107. 1342–1353. 83 indexed citations
14.
Zhang, He-Da, Linhong Jiang, Junchen Hou, et al.. (2018). Circular RNA Hsa_Circ_0072995 Promotes Breast Cancer Cell Migration and Invasion Through Sponge for Mir-30c-2-3p. Epigenomics. 10(9). 1229–1242. 58 indexed citations
15.
Zhong, Shanliang, Jinyan Wang, Junchen Hou, et al.. (2018). Circular RNA Hsa_Circ_0000993 Inhibits Metastasis of Gastric Cancer Cells. Epigenomics. 10(10). 1301–1313. 43 indexed citations
16.
Zhang, Heda, Linhong Jiang, Junchen Hou, et al.. (2018). Exosome: A Novel Mediator in Drug Resistance of Cancer Cells. Epigenomics. 10(11). 1499–1509. 35 indexed citations
17.
Zhu, Lingping, Yunjie He, Junchen Hou, et al.. (2017). The role of circRNAs in cancers. Bioscience Reports. 37(5). 81 indexed citations
18.
Wang, Jinyan, Qian Zhang, Dandan Wang, et al.. (2017). MiR-29a : a potential therapeutic target and promising biomarker in tumors. Bioscience Reports. 38(1). 55 indexed citations
19.
Zhang, Heda, Linhong Jiang, Dawei Sun, Junchen Hou, & Zhenling Ji. (2017). CircRNA: a novel type of biomarker for cancer. Breast Cancer. 25(1). 1–7. 622 indexed citations breakdown →
20.
Yu, Xinnian, Siying Zhou, Jinyan Wang, et al.. (2017). Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies. Breast Cancer. 24(5). 643–657. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gehao Liang Breakdown of academic impact, for papers by Zhenyu Zhong Breakdown of academic impact, for papers by Erhu Fang Breakdown of academic impact, for papers by Qiaozhu Zuo Breakdown of academic impact, for papers by Kefeng Wang Breakdown of academic impact, for papers by Botai Li Breakdown of academic impact, for papers by Zhuojun Zheng Breakdown of academic impact, for papers by Tingting Shao
Rankless by CCL
2026